CHMP recommends eight new drug approvals, six label expansions

It was a pos­i­tive week for the Eu­ro­pean Med­i­cines Agency’s hu­man med­i­cines com­mit­tee (CHMP), which rec­om­mend­ed the ap­proval of eight new drugs in­clud­ing Take­da’s Fruza­qla and As­traZeneca’s Truqap.

The com­mit­tee al­so vot­ed in fa­vor of six new la­bel ex­pan­sions. While the Eu­ro­pean Com­mis­sion has the fi­nal au­thor­i­ty over new drug ap­provals, it typ­i­cal­ly fol­lows CHMP’s rec­om­men­da­tions.

The ap­proval rec­om­men­da­tions in­clude:

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.